{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T22:48:16Z","timestamp":1776725296426,"version":"3.51.2"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,4]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Atopic dermatitis (AD) predisposes to viral skin infections, such as eczema herpeticum (EH), and to bacterial skin infections, such as those caused by <jats:italic toggle=\"yes\">Staphylococcus aureus<\/jats:italic> (SA) and group A streptococcus (GAS). This study evaluated clinical features of EH and its frequency of codetection with SA or GAS in children hospitalized for presumed AD skin infection.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>We retrospectively reviewed clinical data for children \u226418 years of age admitted to a large hospital system for AD with presumed skin infection from January 2004 to December 2018. Those with an alternate primary diagnosis or missing microbiologic data were excluded. Encounters with herpes simplex virus testing were identified as AD with EH (ADEH+) or without (ADEH\u2212). Encounters with bacterial skin culture growth were identified as SA or GAS.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Among 180 AD encounters with suspected skin infection, 133 (74%) were tested for herpes simplex virus. Clinical findings associated with ADEH+ status (n = 61) included fever on admission (59% vs. 32% in ADEH\u2212; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.002), rash on the neck (30% vs. 13%; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.015) and vesicular rash (70% vs. 49%; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.011). Encounters in the ADEH+ group had a longer hospital length of stay compared with encounters in the ADEH\u2212 group [median 4 days (interquartile range 3\u20135 days) vs. 3 days (interquartile range 2\u20133 days); <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001]. GAS was identified in only 1 ADEH+ encounter (2%) versus 15 ADEH\u2212 encounters (26%), <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Providers should maintain a high index of suspicion for EH in children admitted for presumed AD skin infection. GAS was more commonly associated with ADEH\u2212 encounters.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000002542","type":"journal-article","created":{"date-parts":[[2019,11,25]],"date-time":"2019-11-25T06:30:16Z","timestamp":1574663416000},"page":"263-266","source":"Crossref","is-referenced-by-count":3,"title":["Frequency and Clinical Features Associated With Eczema Herpeticum in Hospitalized Children With Presumed Atopic Dermatitis Skin Infection"],"prefix":"10.1097","volume":"39","author":[{"given":"Sunita Ali","family":"Hemani","sequence":"first","affiliation":[{"name":"Emory University School of Medicine, Atlanta, Georgia"},{"name":"Children\u2019s Healthcare of Atlanta, Atlanta, Georgia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary Bond","family":"Edmond","sequence":"additional","affiliation":[{"name":"Children\u2019s Healthcare of Atlanta, Atlanta, Georgia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Preeti","family":"Jaggi","sequence":"additional","affiliation":[{"name":"Emory University School of Medicine, Atlanta, Georgia"},{"name":"Children\u2019s Healthcare of Atlanta, Atlanta, Georgia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Cooley","sequence":"additional","affiliation":[{"name":"Emory University School of Medicine, Atlanta, Georgia"},{"name":"Children\u2019s Healthcare of Atlanta, Atlanta, Georgia."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230912","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/DER.0000000000000034","article-title":"Associations of childhood eczema severity: a US population-based study.","volume":"25","author":"Silverberg","year":"2014","journal-title":"Dermatitis"},{"key":"R2-20230912","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.iac.2016.08.015","article-title":"Infectious complications in atopic dermatitis.","volume":"37","author":"Sun","year":"2017","journal-title":"Immunol Allergy Clin North Am"},{"key":"R3-20230912","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1136\/bmj.b2433","article-title":"Filaggrin gene defects and risk of developing allergic sensitisation and allergic disorders: systematic review and meta-analysis.","volume":"339","author":"Van Den Oord","year":"2009","journal-title":"BMJ"},{"key":"R4-20230912","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1056\/NEJMra1011040","article-title":"Filaggrin mutations associated with skin and allergic diseases.","volume":"365","author":"Irvine","year":"2011","journal-title":"N Engl J Med"},{"key":"R5-20230912","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jid.2017.08.039","article-title":"Epidemiology of eczema herpeticum in hospitalized U.S. children: analysis of a nationwide cohort.","volume":"138","author":"Hsu","year":"2018","journal-title":"J Invest Dermatol"},{"key":"R6-20230912","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jaci.2009.05.020","article-title":"Phenotype of atopic dermatitis subjects with a history of eczema herpeticum.","volume":"124","author":"Beck","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"R7-20230912","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/sj.jid.5700657","article-title":"Risk factors of atopic dermatitis patients for eczema herpeticum.","volume":"127","author":"Peng","year":"2007","journal-title":"J Invest Dermatol"},{"key":"R8-20230912","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jpeds.2012.03.057","article-title":"Eczema herpeticum in children: clinical features and factors predictive of hospitalization.","volume":"161","author":"Luca","year":"2012","journal-title":"J Pediatr"},{"key":"R9-20230912","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.jaci.2003.07.001","article-title":"Viral infections in atopic dermatitis: pathogenic aspects and clinical management.","volume":"112","author":"Wollenberg","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"R10-20230912","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1525-1470.2012.01860.x","article-title":"Empiric antibiotics and outcomes of children hospitalized with eczema herpeticum.","volume":"30","author":"Aronson","year":"2013","journal-title":"Pediatr Dermatol"},{"key":"R11-20230912","doi-asserted-by":"crossref","first-page":"409","DOI":"10.5114\/pdia.2014.44017","article-title":"Role of primary and secondary prevention in atopic dermatitis.","volume":"32","author":"Oszukowska","year":"2015","journal-title":"Postepy Dermatol Alergol"},{"key":"R12-20230912","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1056\/NEJMra074081","article-title":"Atopic dermatitis.","volume":"358","author":"Bieber","year":"2008","journal-title":"N Engl J Med"},{"key":"R13-20230912","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.jaci.2012.06.019","article-title":"Staphylococcus aureus \u03b1-toxin modulates skin host response to viral infection.","volume":"130","author":"Bin","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"R14-20230912","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1542\/peds.2011-0948","article-title":"Delayed acyclovir and outcomes of children hospitalized with eczema herpeticum.","volume":"128","author":"Aronson","year":"2011","journal-title":"Pediatrics"},{"key":"R15-20230912","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1525-1470.2010.01356.x","article-title":"The clinical spectrum and therapeutic challenge of eczema herpeticum.","volume":"28","author":"Frisch","year":"2011","journal-title":"Pediatr Dermatol"},{"key":"R16-20230912","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1525-1470.2010.01293.x","article-title":"Children with atopic dermatitis appear less likely to be infected with community acquired methicillin-resistant Staphylococcus aureus: the San Diego experience.","volume":"28","author":"Matiz","year":"2011","journal-title":"Pediatr Dermatol"},{"key":"R17-20230912","doi-asserted-by":"crossref","first-page":"e808","DOI":"10.1542\/peds.2008-2217","article-title":"Treatment of Staphylococcus aureus colonization in atopic dermatitis decreases disease severity.","volume":"123","author":"Huang","year":"2009","journal-title":"Pediatrics"},{"key":"R18-20230912","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0166-3542(88)90048-4","article-title":"Antiherpes activity of the immunomodulator OK-432, a streptococcal preparation, in immunosuppressed mice.","volume":"10","author":"Ikeda","year":"1988","journal-title":"Antiviral Res"},{"key":"R19-20230912","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1348-0421.1989.tb01996.x","article-title":"Protection of OK-432, a Streptococcus pyogenes preparation, against lethal infection of mice with herpes simplex virus.","volume":"33","author":"Harada","year":"1989","journal-title":"Microbiol Immunol"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000002542","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T22:33:39Z","timestamp":1694558019000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000002542"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000002542","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]}}}